Martin Allen-Auerbach

5.1k total citations
78 papers, 3.5k citations indexed

About

Martin Allen-Auerbach is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Martin Allen-Auerbach has authored 78 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Radiology, Nuclear Medicine and Imaging, 43 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in Martin Allen-Auerbach's work include Medical Imaging Techniques and Applications (31 papers), Prostate Cancer Treatment and Research (20 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). Martin Allen-Auerbach is often cited by papers focused on Medical Imaging Techniques and Applications (31 papers), Prostate Cancer Treatment and Research (20 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). Martin Allen-Auerbach collaborates with scholars based in United States, Germany and Italy. Martin Allen-Auerbach's co-authors include Johannes Czernin, Wolfgang Weber, Matthias Benz, Heinrich R. Schelbert, Fritz C. Eilber, Ken Herrmann, Michael E. Phelps, Michael E. Phelps, Barbara J. Fueger and William D. Tap and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Martin Allen-Auerbach

76 papers receiving 3.4k citations

Peers

Countries citing papers authored by Martin Allen-Auerbach

Since Specialization

Citations

This map shows the geographic impact of Martin Allen-Auerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Allen-Auerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Allen-Auerbach more than expected).

Fields of papers citing papers by Martin Allen-Auerbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Allen-Auerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Allen-Auerbach. The network helps show where Martin Allen-Auerbach may publish in the future.

Co-authorship network of co-authors of Martin Allen-Auerbach

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Allen-Auerbach. A scholar is included among the top collaborators of Martin Allen-Auerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Allen-Auerbach. Martin Allen-Auerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	177Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer: Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial 2025 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Luca Valle, Holly Wilhalme, (unknown), (unknown), Javier Casillas, (unknown), Tenghui Ma, (unknown), (unknown), (unknown), Joanne B. Weidhaas, Donatello Telesca, Masahiro Nakayama, (unknown), Robert E. Reiter, Martin Allen-Auerbach, (unknown), Michael L. Steinberg, Jérémie Calais	0
2	Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data 2024 ·Journal of Nuclear Medicine ·Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, (unknown), Elisa M. Ledet, (unknown), (unknown), Courtney Lawhn-Heath, (unknown), Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Sólnes, Thomas A. Hope, Oliver Sartor, Jérémie Calais, Andrei Gafita	4
3	Efficacy and toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer in a real-world setting: Results from the U.S. Expanded Access Program and comparisons with phase 3 VISION data. 2024 ·Journal of Clinical Oncology ·Jérémie Calais, Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, (unknown), Elisa M. Ledet, (unknown), (unknown), Courtney Lawhn-Heath, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Sólnes, Thomas A. Hope, Oliver Sartor, Andrei Gafita	1
4	FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Masatoshi Hotta, Andrea Farolfi, Tristan Grogan, (unknown), (unknown), (unknown), Giuseppe Carlucci, Shadfar Bahri, Ali Salavati, Matthias Benz, Daniel Silverman, Pawan Gupta, Andrew Quon, Martin Allen-Auerbach, Johannes Czernin, Jérémie Calais	3
5	Differences and Common Ground in¹⁷⁷Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers 2024 ·Journal of Nuclear Medicine ·Andrea Farolfi, Wesley R. Armstrong, Loïc Djaileb, Andrei Gafita, Masatoshi Hotta, Martin Allen-Auerbach, Lena M. Unterrainer, Wolfgang P. Fendler, Matthew B. Rettig, Matthias Eiber, Michael S. Hofman, Boris Hadaschik, Ken Herrmann, Johannes Czernin, Jérémie Calais, Matthias Benz	9
6	PSMA-Negative Lesion Progression Under¹⁷⁷Lu-PSMA Radioligand Therapy 2023 ·Journal of Nuclear Medicine ·Vishnu Murthy, Martin Allen-Auerbach, Richard Y. Lam, Dawn Owen, Johannes Czernin, Jérémie Calais	4
7	Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression 2022 ·Cancer Imaging ·Kathleen Ruchalski, Grace Hyun J. Kim, Michael Douek, Steven S. Raman, Maitraya Patel, Victor Sai, Antonio Gutiérrez, Benjamin D. Levine, (unknown), Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, (unknown), Matthew S. Brown, Jonathan Goldin	2
8	Safety of PSMA-Targeted Molecular Radioligand Therapy with ¹⁷⁷Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312) 2021 ·Journal of Nuclear Medicine ·Jérémie Calais, Johannes Czernin, Pan Thin, J Gartmann, Kathleen Nguyen, Wesley R. Armstrong, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, (unknown), Magnus Dahlbom, (unknown), Rouzbeh Esfandiari, David Ranganathan, Ken Herrmann, Matthias Eiber, Wolfgang P. Fendler, Ebrahim S. Delpassand	29
9	Impact of ⁶⁸Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence 2017 ·Journal of Nuclear Medicine ·Jérémie Calais, Wolfgang P. Fendler, Matthias Eiber, J Gartmann, Fang‐I Chu, Nicholas G. Nickols, Robert E. Reiter, Matthew B. Rettig, Leonard S. Marks, Thomas E. Ahlering, Linda My Huynh, Roger Slavik, Pawan Gupta, Andrew Quon, Martin Allen-Auerbach, Johannes Czernin, Ken Herrmann	118
10	Human Biodistribution and Radiation Dosimetry of ¹⁸F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway 2016 ·Journal of Nuclear Medicine ·Martin Barrio, Claudio Spick, Caius G. Radu, Michael Laßmann, Uta Eberlein, Martin Allen-Auerbach, Christiaan Schiepers, Roger Slavik, Johannes Czernin, Ken Herrmann	18
11	SPECT- and PET-Based Patient-Tailored Treatment in Neuroendocrine Tumors 2015 ·Clinical Nuclear Medicine ·Rudolf A. Werner, Christina Bluemel, Michael Laßmann, Theodor Kudlich, Takahiro Higuchi, Egesta Lopci, Martin Allen-Auerbach, Patrick M. Colletti, Domenico Rubello, Maria Chiara Zatelli, Ken Herrmann	9
12	Perceived Misinterpretation Rates in Oncologic ¹⁸F-FDG PET/CT Studies: A Survey of Referring Physicians 2014 ·Journal of Nuclear Medicine ·Dimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, Ken Herrmann, Kelsey L. Pomykala, Trond Velde Bogsrud, Rathan M. Subramaniam, Val J. Lowe, Martin Allen-Auerbach	7
13	PET/CT in Oncology: Current Status and Perspectives 2013 ·Current Radiology Reports ·Johannes Czernin, Martin Allen-Auerbach, David A. Nathanson, Ken Herrmann	73
14	Squamous Papilloma of the Oral Cavity and Oropharynx on 18F-FDG PET/CT Imaging 2012 ·Clinical Nuclear Medicine ·Dimitrios Karantanis, Martin Allen-Auerbach, Johannes Czernin	1
15	Computer-aided quantitative bone scan assessment of prostate cancer treatment response 2012 ·Nuclear Medicine Communications ·Matthew S. Brown, (unknown), Hyun J. Kim, Martin Allen-Auerbach, (unknown), (unknown), (unknown), (unknown), Judy Ho, Michael J. Morris, Steven M. Larson, Howard I. Scher, Jonathan Goldin	36
16	Breast Cancer 2011 ·Methods in molecular biology ·Johannes Czernin, Matthias Benz, Martin Allen-Auerbach	2
17	Treatment Monitoring by ¹⁸F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors 2008 ·Journal of Nuclear Medicine ·Matthias Benz, Vladimir Evilevitch, Martin Allen-Auerbach, Fritz C. Eilber, Michael E. Phelps, Johannes Czernin, Wolfgang Weber	90
18	Novel features in a patient homozygous for the L347P mutation in the PINK1 gene 2006 ·Parkinsonism & Related Disorders ·(unknown), James W. Tetrud, Martin Allen-Auerbach, J. William Langston, Birgitt Schüle	11
19	Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients 2005 ·Molecular Imaging and Biology ·Barbara J. Fueger, Wolfgang Weber, Andrew Quon, (unknown), Martin Allen-Auerbach, Benjamin S. Halpern, Osman Ratib, Michael E. Phelps, Johannes Czernin	77
20	Comparison between 2-deoxy-2-[F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma 2004 ·Molecular Imaging and Biology ·Martin Allen-Auerbach, Andrew Quon, Wolfgang Weber, (unknown), (unknown), (unknown), Osman Ratib, Mitch A. Phelps, Johannes Czernin	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact